Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Peilong Biomedical Technology is a specialized biotechnology company based in Chengdu, China, that focuses on the research, development, and production of high-quality peptides and pharmaceutical intermediates. The company provides a comprehensive suite of services including custom peptide synthesis, isotope labeling, and complex chemical modifications such as cyclization and phosphorylation. Peilong Bio serves as a strategic partner for global pharmaceutical companies and academic institutions, offering technical expertise in the synthesis of challenging sequences and large-scale manufacturing. Their facilities are designed to support drug discovery and development through the provision of high-purity reagents and specialized biochemical tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Peilong Biomedical Technology.